Clinical Trial Update: Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral Origin [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial completed evaluating the antipyretic efficacy of aspirin versus placebo in patients with acute febrile upper respiratory tract infect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Bayer | Conditions: Respiratory Tract Infections, Fever | Phase 4 | Status: COMPLETED